Prognostic Value of Programed Cell Death-1 Ligand Expression in Colorectal Cancer and Its Correlation with Cytotoxic Tumor-Infiltrating Lymphocytes

Programmed death protein 1 (PD1) mRNA expression as a screening and diagnostic tool in colon cancer

Association of CTLA4 and PD-L1 immunohistchemical expression with various clinicopathological parameters and survival in non–small-cell lung cancer

FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy

The Expression of Immune Checkpoint Inhibitors PDL-1 and CTLA-4 in Pancreatic Versus Non-Pancreatic Periampullary Adenocarcinoma: An Immunohistochemical Study

Programmed Cell Death Ligand 1(PD-L1) Expression in Molecular Subtypes of Breast Cancer

CD8&CD163 EXPRESSION IN TUMOR MICROENVIRONMENT OF RENAL CELL CARCINOMA AND THEIR RELATION TO PD-L1 EXPRESSION

Significance of expression of PD-L1, VEGF and CD8+ T cells in ovarian serous carcinoma: an Immunohistochemical study

Histopathological and Immunohistochemical Study of the Prognostic Significance of Cox2 and CDX2 Expression in the Available Cases of Colorectal Carcinoma

The impact of CD44 immunoreactivity on survival of patients with colorectal cancer